The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

After a daylong meeting discussing tentative changes to the nation's COVID-19 vaccine strategy, the FDA's Vaccines and Related Biological Products Advisory Committee voted 21-0 recommending the ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

The COVID recommendation was part of documents the Food and Drug Administration released Monday that discuss simplifying and ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

The vaccine advisory panel for the Food and Drug Administration (FDA) on Thursday voted to recommend matching the composition ...

U.S. health officials will present a new vaccine plan that recommends an annual COVID-19 booster and proposes changes to the ...